Navigation Links
Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

tivity and impulsivity in children aged 6 to 17 years previously diagnosed with ADHD, as measured by several standardized tests when compared to placebo treatment.

In the two short-term trials, the primary endpoint was a reduction in ADHD symptoms as measured by the ADHD Rating Scale (ADHD-RS-IV). ADHD-RS-IV is a standardized, validated test for assessing symptoms of ADHD in children and for assessing their response to treatment. This scale, which contains 18 items, is based on the ADHD diagnostic criteria as defined in the APA's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision(R).

In the first trial, 301, investigators compared 2 mg, 3 mg or 4 mg GXR doses to placebo during an eight-week treatment period. The participants randomized to GXR all began at the 1 mg dose. At weekly visits, doses were titrated in 1 mg increments over the first four weeks to achieve the randomized dose. Then, doses were tapered down weekly so that all participants randomized to GXR received the 1 mg dose at week eight.

Participants achieved overall significant mean reductions from baseline in ADHD-RS-IV total scores by study end, -16.7 points vs. -8.9 for placebo (P <.0001). Investigators observed improvement in ADHD-RS-IV scores as early as two weeks after dosing began, with significant improvement in all GXR dose groups occurring at the third week.

Effect sizes, calculated using results from the ADHD-RS-IV scores and evaluated using weight-adjusted actual doses, were 0.44 (0.01 to 0.04 mg/kg), 0.58 (0.05 to 0.08 mg/kg), 1.19 (0.09 to 0.12 mg/kg), and 1.34 (0.13 to 0.17 mg/kg). In general, effect sizes are categorized as small (0.2), medium (0.5) and large (0.8).

In the second short-term trial, 304, investigators examined 1 mg, 2 mg, 3 mg and 4 mg doses and placebo during nine weeks of treatment. During the first three weeks, patients started at 1 mg with doses escalating in once- weekly 1 mg increments to achieve the
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:3/27/2015)... , March 27, 2015 ... prospects for leading ophthalmic drug companies  What ... pharma ophthalmic industry ? Visiongain,s brand new report ... opportunities and prospects there. Our 242-page report ... lucrative areas in the industry and the future market ...
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)... 2015 Concord Medical Services Holdings Limited ... ), a leading specialty hospital management solution provider ... and diagnostic imaging centers in China ... purchase agreement under which Concord Medical Services (International) ... Company, agreed to acquire the Fortis Surgical Hospital ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
...  RSB Spine, LLC, today announced allowance of U.S Patent ... of InterPlate® cervical and lumbar intervertebral fusion devices. ... held medical device company. News releases and other ... Internet at: www.rsbspine.com and ...
... Jan. 10, 2012 ThermoGenesis Corp. (NASDAQ: ... services that process and store human cell concentrates, said ... with Arthrex, Inc., under which Arthrex will market ThermoGenesis, ... preparation of autologous Platelet Rich Plasma (PRP) and Bone ...
Cached Medicine Technology:Thermogenesis Signs Worldwide Res-Q System Distribution Agreement With Arthrex for Sports Medicine Applications 2
(Date:3/29/2015)... March 29, 2015 At this ... platform provides basic health information around medical conditions ... discuss these challenges as well as helping them ... addresses six medical conditions using evidenced based information ... engage in conversations around them., ...
(Date:3/29/2015)... “Health is an endo thing, from ... more about the cannabinoid system … we learn it’s ... Go Endo-Cannabinoid Update ~ new on the Bryan ... Publius, of The Cannabis Papers: A citizen’s guide to ... (PubMed) cannabinoid system (CS) articles discussing: cannabinoids in the ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of its ... and coolest applications on the market for iOS, Android, ... technology expert, conducted the app review and shared with ... with knights, nature, and peasants. , The first ... Eurogamer. The popularity of these games grew over the ...
(Date:3/28/2015)... 2015 The California-based leading wig brand ... customer shopping on UniWigs during the Easter Holidays from ... big promotion on April Fools’ Day. , As the ... around the corner. Easter Festival, with religious origins to ... major holiday after Christmas. The best wig provider, UniWigs, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Centurion Service Group ... auction on Thursday, April 2 at their Las Vegas warehouse, ... NV 89081. The sale, which consists of equipment from hospitals ... promptly at 9 a.m. PDT. , Buyers will find ... surgery equipment. “We are a one-stop-shop,” said Erik Tivin, CEO ...
Breaking Medicine News(10 mins):Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2
... to a new research, Atkins diet-low carbohydrate diet can increase ... decline in the production of a fatty acid in the ... ,The fatty acid butyrate, which protects against colorectal cancer, is ... from the Rowett Research Institute, in Aberdeen, found that ...
... Those who uphold the law often end up violating the ... mosquitoes in the Indian capital . ,The local ... House courts and the National Human Rights Commission (NHRC) for ... fevers. ,Health officials said that during their field ...
... AIDS charity AVERT is today launching Stop AIDS in Children, ... child AIDS deaths and half a million new infant ... year's G8 summit in Germany, the leaders of the world's ... AIDS deaths by committingspecific funds for prevention of mother-to-child transmission ...
... toward offering vaccinations against cervical cancer for girls as young ... by late next year. The Joint Committee on Vaccination ... against the human papilloma virus (HPV), a sexually transmitted infection ... Department of Health said it had agreed "in principle" to ...
... rehab stint pretty 'serious' and doesn't want to 'mess around' this ... said that the actress will be in the rehab for more ... for her stay due to her work schedule. ,"She ... know how much longer because of her work schedule, but she ...
... nurses who had blocked a main road in front of the ... nurses had set up camp in the street in the aftermath ... ,An AFP reporter saw several units of police in riot gear, ... cleared the street itself, the nurses managed to continue camping on ...
Cached Medicine News:Health News:Notice Sent to Courts Asking Them to Stop Courting Mosquitoes 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2Health News:Polish Police Break Up Nurses' Pay Protest 2
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of total protein in urine and c.s.f....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
For the quantitative in vitro determination of Apolipoprotein A-1 in human serum....
Medicine Products: